HF
CRVO icon

HRT Financial’s CervoMed CRVO Stock Holding History

HRT Financial’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,330
Closed -$113K – 3937
2025
Q4 		$113K Buy
+14,330
New +$115K ﹤0.01% 2764
2025
Q3 		– Sell
-10,434
Closed -$65K – 2978
2025
Q2 		$65K Buy
+10,434
New +$88.9K ﹤0.01% 2272
2025
Q1 		– Sell
-12,987
Closed -$30K – 2643
2024
Q4 		$30K Buy
+12,987
New +$126K ﹤0.01% 2159
2021
Q3 		– Sell
-150
Closed -$8K – 3359
2021
Q2 		$8K Buy
+150
New +$8.29K ﹤0.01% 2752
2020
Q3 		– Sell
-828
Closed -$60K – 1963
2020
Q2 		$60K Buy
+828
New +$50.4K ﹤0.01% 1301

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's CRVO Position: Q1 2026 in Review

HRT Financial sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 14,330 shares — an estimated $113K sold.

HRT Financial first reported a position in CRVO in Q2 2020 and held it in 5 quarters. The position peaked at $113K in Q4 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • HRT Financial reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 14,330 CervoMed shares in Q1 2026, an estimated $113K.
  • HRT Financial first reported a position in CervoMed in Q2 2020 and held it in 5 quarters.
  • HRT Financial's CervoMed position peaked at $113K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.